Neuroleptic Malignant Syndrome
NEEDS IMMEDIATE MEDICAL ATTENTION!
Neuroleptic malignant syndrome (NMS) is a life-threatening idiosyncratic reaction to antipsychotic drugs characterized by fever, altered mental status, muscle rigidity, and autonomic dysfunction.
Cluster Number:
Wiki Number: PW132
Diagnosis: Neuroleptic Malignant Syndrome-NEEDS IMMEDIATE MEDICAL ATTENTION!
US Patients:
World Patients:
Sex Ratio: M+;F
Age Onset:
Brain Area:
Symptoms: increased body temperature, confusion, sweating, rigid muscles, antonomic imbalance: can be fatal within 3 days!
Progression: TOO COMPLEX TO SUMMARIZE HERE!
Causes: Responses to neuroleptic or antipsychotic medicines – 10% CAN BE FATAL! (Includes rapid decrease in “L-Dopa” used for Parkinson’s)
Medications:
Therapies:
Youtube Video: Neuroleptic Malignant Syndrome
Amazon or Library Book:
Neuroleptic Malignant Syndrome and Related Conditions
Click the book to link or buy from Amazon.
Support Group: nmsis.org; 607-674-7920
(Neuroleptic Malignant Syndrome Information Service, Inc.)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literatureby Brian S Barnett on December 31, 2022
CONCLUSIONS: Given frequent comorbidity of conditions associated with catatonia in patients with cerebral palsy, as well as routine treatment with medications that can induce NMS, such as metoclopramide and anticholinergics, catatonia and NMS may be underreported in the cerebral palsy patient population, despite being highly treatable. Possible underdiagnosis of catatonia in patients with cerebral palsy may be because of misattribution of overlapping features between the 2 conditions to cerebral...
- The management challenges of a case with Flupentixol-induced neuroleptic malignant syndromeby Forouzan Elyasi on December 30, 2022
CONCLUSION: In conclusion, there were suggestions for the management challenges of NMS in patients receiving LA injectable antipsychotic agents.
- Malignant complications of masturbation - a case studyby Wojciech Mędrala on December 21, 2022
We present a case of a 32-years-old female patient diagnosed with paranoid schizophrenia for many years who has developed neuroleptic malignant syndrome (NMS) as a result of long-acting antipsychotic's injection. Since the initial ineffectiveness of benzodiazepines, the course of electroconvulsive therapy (ECT) has been carried out. In spite of the initial promising response to ECT 3 weeks after the admission her somatic and mental state deteriorated greatly, that was hardly explicable solely by...
- Thymic Hyperplasia-Associated Autoimmune Encephalitis Mimicking Neuroleptic Malignant Syndrome: A Case Reportby Mohammad Abu-Abaa on December 12, 2022
Anti-NMDA (N-methyl-D-aspartate) receptor encephalitis is a common autoimmune encephalitis. It is commonly associated with underlying malignancy. We present a 24-year-old patient with sudden onset of behavioral changes and acute psychosis who was treated with antipsychotics followed by the development of generalized rigidity, facial twitching, and sympathetic overactivity. MRI and EEG were inconclusive. The neuroleptic malignant syndrome was presumed and bromocriptine was started. Multiple...